Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON58143Not yet recruiting
Open-label trial in rheumatoid arthritis (RA) (3 arms), sponsored by Queen Mary University of London. Primary endpoint: Clinical Disease Activity Index at 16 weeks. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON58143.